New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
08:14 EDTISRG, FLDM, CPHDLeerink to host a bus tour
Devices & DNA Bus Tour travels throughout Northern and Southern California on December 10-13. Cepheid--CPHD, Intuitive Surgical--ISRG and Fluidigm--FLDM will be visited on December 13.
News For CPHD;ISRG;FLDM From The Last 14 Days
Check below for free stories on CPHD;ISRG;FLDM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 23, 2014
05:50 EDTISRGIntuitive Surgical upgraded to Buy from Hold at Stifel
Stifel upgraded Intuitive Surgical to Buy with a $600 price target following the company's better than expected Q2 results. Shares were also upgraded this morning at Raymond James.
05:49 EDTISRGIntuitive Surgical upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
July 22, 2014
18:33 EDTISRGOn The Fly: After Hours Movers
UP AFTER EARNINGS: Broadcom (BRCM), consensus up 3% after reporting second quarter results... Intuitive Surgical (ISRG), up 10.4%... Manhattan Associates (MANH), up 3%... Robert Half International (RHI), up 3.9%... Hawaiian Holdings (HA), up 3.1%... Microsoft (MSFT), up just under 1%... FMC Technologies (FTI), up 1.1%. ALSO HIGHER: Ballard Power Systems (BLDP), up 2.7% following purchase order from New Flyer Industries... Unwired Planet (UPIP), up 2.4% after filing a lawsuit against Microsoft for breach of contract. NOTABLE: Puma Biotechnology (PBYI), up 193.8% after reporting positive top line results from Phase III PB272 trial. DOWN AFTER EARNINGS: Xilinx (XLNX), down 8.7%... Apple (AAPL), down after reporting third quarter results and fourth quarter guidance... Juniper Networks (JNPR), down 4.7%... ALSO LOWER: Farmland Partners (FPI), down 3.8% after filing to sell 3.72M shares of common stock.
17:00 EDTISRGIntuitive Surgical narrows FY14 procedure growth view to 5%-8% from 2%-8%
Subscribe for More Information
16:57 EDTISRGIntuitive Surgical sees international procedure growth 'lumpy' QoQ
Subscribe for More Information
16:39 EDTISRGIntuitive Surgical sees capital pressures in most hospitals to continue
Subscribe for More Information
16:17 EDTISRGIntuitive Surgical reports Q2 adjusted EPS $3.73, GAAP EPS $2.77
Consensus $2.83. Intuitive Surgical ended Q2 with $2B in cash, cash equivalents, and investments, a decrease of $920M during the quarter, primarily reflecting the impact of $1B utilized during the quarter to repurchase shares of its common stock.
16:13 EDTISRGIntuitive Surgical rises after results, first look
Subscribe for More Information
16:06 EDTISRGIntuitive Surgical reports Q2 EPS $2.77, consensus $2.83
Subscribe for More Information
15:30 EDTISRGNotable companies reporting after market close
Subscribe for More Information
13:57 EDTISRGEarnings Preview: Intuitive Surgical share price flat over last 12 months
Subscribe for More Information
11:36 EDTISRGIntuitive Surgical July weekly volatility increases into Q2 and outlook
Subscribe for More Information
July 18, 2014
09:44 EDTCPHDCepheid trades sharply lower after earnings, levels to watch
Subscribe for More Information
09:24 EDTCPHDOn The Fly: Pre-market Movers
Subscribe for More Information
07:37 EDTISRGIntuitive Surgical Q2 expectations 'appear achievable,' says Jefferies
Jefferies says its hospital and surgeon channel checks increase its comfort level around initial Xi demand and overall placements ahead of Intuitive Surgical's Q2 results, though the firm cautions that visibility on utilization is low and procedures could come in below consensus. Jefferies thinks expectations for Q2 "appear achievable" since they incorporate near-term challenges. The firm keeps a Buy rating on the stock with a $465 price target.
July 17, 2014
17:42 EDTCPHDCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
17:31 EDTCPHDCepheid sees significant step up in Q4 revenue
17:31 EDTCPHDCepheid sees Q3 non-GAAP EPS (1c)-1c, consensus (8c)
Subscribe for More Information
16:14 EDTCPHDCepheid sees FY14 adjusted EPS 10c-13c, may not compare to consensus (37c)
Subscribe for More Information
16:13 EDTCPHDCepheid reports Q2 EPS (14c), consensus (14c)
Reports Q2 revenue $116.5M, consensus $115.56M.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use